Project
BMS_IM101-863
Completed - recruitment closed ยท 2022 until 2025
Peischl Shirin, Peischl Riana, Bartz-Batliner Mira, Rubbert-Roth Andrea, Haller Christoph, Pirker Ian, Hutz Carina Liane
Type
Range
Units
Status
Start Date
End Date
Financing
Brief description/objective
A Phase 3, Randomized, Head-to-head, Single-blind Study to Compare the Response to Treatment with Subcutaneous Abatacept vs Adalimumab, on Background Methotrexate, in Adults with Early, Seropositive Rheumatoid Arthritis Who Have "Shared Epitope" HLA Class II Risk Alleles and Have an Inadequate Response to Methotrexate